FDA Approves Momelotinib for Myelofibrosis With Anemia
The US Meals and Drug Administration (FDA) at this time authorized the JAK inhibitor momelotinib (Ojjaara) for myelofibrosis sufferers with...
The US Meals and Drug Administration (FDA) at this time authorized the JAK inhibitor momelotinib (Ojjaara) for myelofibrosis sufferers with...
June 20, 2023 – Older folks taking day by day low-dose aspirin have a 20% larger threat for developing anemia,...
Researchers at College School London and on the College of Ghana have developed a smartphone-based system that may detect anemia...